Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
about
Adiponectin and leptin molecular actions and clinical significance in breast cancerNew insight into adiponectin role in obesity and obesity-related diseases.Adiponectin actions in the cardiovascular system.Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men.Serum adiponectin levels in advanced-stage Parkinson's disease patients.Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.Cardioprotection by adiponectin.Targeting adiponectin for cardioprotection.Plasma adiponectin complexes have distinct biochemical characteristics.Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG studyThe adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growthThe role of fat topology in the risk of disease.Impact of simvastatin on adipose tissue: pleiotropic effects in vivo.Potential of adiponectin as a cardioprotective agent.Adiponectin and hypertension.Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPARγ-agonist activity.Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension.Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery.Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population.CNS Targets of Adipokines.Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice.
P2860
Q26998555-D5B94FB4-B12C-4CB3-B331-BAE483DAA473Q33943727-9AC19D77-27EF-41FB-B374-9A2B47E6660DQ34001251-BBC3780B-7091-428A-8E19-36A3898D2FBAQ34552667-939B9540-1724-4E0A-90D6-E336A0190BD5Q35101405-F4196719-C0F8-4A78-ABD1-7E334C08CD61Q35218922-C23D54D6-4BB5-428B-881D-EB1F495536C4Q36510181-9FF6F3B5-45E1-485C-9327-6FE1496E1C33Q36539480-79EFE52C-E5BB-460A-A475-E8196D136C08Q36578847-AAD15065-B036-4367-A974-AA8DC35D1D3EQ36868309-E8963D12-696B-4298-B8F8-E3A0F053F4C7Q37151146-5C050E11-2FD2-4206-B532-5FB1E88CF4E9Q37366402-89A0CE79-CFCA-4A7E-9257-36B878380A52Q37482967-59D94C00-D73A-4EF4-B50D-32DDAEAB7DA2Q37608586-01C7DAE6-F5C8-4050-93E8-DF6BA50313A0Q37798714-2845F191-EA7B-4E3D-B71B-AF40265E52D6Q39325795-BEF7A940-20A0-4D67-B0B7-9237264F678FQ42668786-04CAEE38-278F-42D0-92C2-D33FB24EBE5AQ42818117-395FF5C2-F650-4803-A741-2229467D214DQ43548500-80904560-C87B-4F45-A4F4-5A047D410AD6Q44948381-9297B5AB-E000-4925-B9A4-598505DEC83BQ45215904-4CBFAEB4-B07B-48DA-9A9E-E5CB3EF7C67CQ46107124-89D518EE-D4DE-41F2-B92D-E02EAF0AD208Q47978333-0FE8DB19-0A16-4F91-A0E6-B87A3799272AQ53433569-2F4D566B-96A2-4770-89BE-C959CA1000F5
P2860
Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
@en
type
label
Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
@en
prefLabel
Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
@en
P2093
P1476
Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
@en
P2093
Azumi Nagasawa
Hidehiko Kondo
Hideki Kobayashi
Hiroyuki Nagaretani
Hitoshi Nishizawa
Kazuhisa Maeda
Ken Kishida
Koji Ohashi
Masahiro Kumada
Norikazu Maeda
P304
P356
10.1016/S0006-291X(03)00940-9
P577
2003-06-01T00:00:00Z